Choroidal Neovascularization
📧 Sign up to get email alerts when something new happens for Choroidal Neovascularization.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia [Phase 2]
Phase 2 trial assessing safety and efficacy of Combretastatin A4 Phosphate for choroidal neovascularization secondary to pathologic myopia h…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study [Phase 1]
Phase 1 pilot study evaluating intravitreal adalimumab for refractory diabetic retinopathy, choroidal neovascularization, or uveitis.
-
CLINICAL_TRIALS trial_result · 2011-05-27Clinical Trial Update: Optic Nerve and Retinal Functions With Bevacizumab
This trial update reports on optic nerve and retinal function outcomes in eyes with choroidal neovascularization treated with bevacizumab.
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib [Phase 3]
A Phase 3 trial comparing verteporfin PDT plus intravitreal triamcinolone versus verteporfin PDT plus intravitreal pegaptanib for age-relate…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization [Phase 3]
Phase 3 trial evaluating verteporfin photodynamic therapy added to ranibizumab versus ranibizumab alone for subfoveal choroidal neovasculari…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-12Clinical Trial Update: Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration [Phase 2]
A Phase 2 clinical trial evaluated infliximab, sirolimus, and daclizumab for age-related macular degeneration, with results posted after com…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Bevacizumab Effect on Blood Velocity
A completed clinical trial evaluating how bevacizumab affects blood velocity in choroidal neovascularization.
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) [Phase 2, Phase 3]
A Phase 2/3 trial evaluating verteporfin photodynamic therapy in combination with ranibizumab for subfoveal choroidal neovascularization due…
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration [Phase 3]
This update reports the completion and posted results of the Phase 3 SUSTAIN trial evaluating ranibizumab for subfoveal choroidal neovascula…
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD [Phase 4]
Open-label Phase 4 trial of Macugen in subjects with neovascular age-related macular degeneration was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: A Study Of Early Markers Of Choroidal Neovascularization
Pfizer-sponsored clinical trial investigating early markers of choroidal neovascularization in age-related macular degeneration has been ter…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) [Phase 2]
A Phase 2 RADICAL trial evaluated reduced fluence Visudyne in combination with an anti-VEGF agent and dexamethasone for choroidal neovascula…
-
CLINICAL_TRIALS trial_result · 2010-03-29Clinical Trial Update: Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD [Phase 2]
Open-label Phase 2 pilot study of TG100801 for choroidal neovascularization due to age-related macular degeneration has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-03-12Clinical Trial Update: Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease [Phase 1]
A Phase 1 trial of talaporfin sodium photodynamic therapy for advanced age-related macular degeneration has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-01-08Clinical Trial Update: Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. [Phase 1]
Phase 1 safety study evaluating ranibizumab injections to treat choroidal neovascularization not caused by age-related macular degeneration.…
-
CLINICAL_TRIALS trial_result · 2009-10-05Clinical Trial Update: Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)
The AMD DOC Study, funded by Johns Hopkins University, investigates the detection of onset of new choroidal neovascularization in age-relate…
-
CLINICAL_TRIALS trial_result · 2009-04-07Clinical Trial Update: Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV [Phase 3]
A Phase 3 clinical trial comparing ranibizumab monotherapy with combined verteporfin therapy for subfoveal choroidal neovascularization due …
-
CLINICAL_TRIALS trial_result · 2009-02-03Clinical Trial Update: Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) [Phase 1]
Phase 1 trial evaluating bevacizumab (Avastin) infusion for choroidal neovascularization not associated with age-related macular degeneratio…
-
CLINICAL_TRIALS trial_result · 2008-08-18Clinical Trial Update: A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [Phase 1, Phase 2]
A completed Phase 1/2 dose-escalation trial evaluating intravitreal Sirna-027 in patients with subfoveal choroidal neovascularization second…
-
CLINICAL_TRIALS trial_result · 2008-07-11Clinical Trial Update: Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV) [Phase 3]
A Phase 3 study evaluated intravitreal bevacizumab for choroidal neovascularization associated with non-age-related macular degeneration; th…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration [Phase 1]
Phase I clinical trial evaluating corticosteroid treatment for ill-defined choroidal neovascularization in age-related macular degeneration …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Fluocinolone Implant to Treat Macular Degeneration [Phase 1]
An NEI-sponsored Phase 1 trial evaluating a fluocinolone implant for macular degeneration (including choroidal neovascularization) has compl…
-
CLINICAL_TRIALS trial_result · 2008-01-24Clinical Trial Update: Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
This clinical trial update reports on intraocular pressure immediately after intravitreal injection of ranibizumab in patients with choroida…
-
CLINICAL_TRIALS trial_result · 2007-09-26Clinical Trial Update: Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy [Phase 3]
This document covers a Phase 3 trial evaluating off-label bevacizumab (Avastin) for serosanguinous maculopathy. The study targets choroidal …
-
CLINICAL_TRIALS trial_result · 2006-10-27Clinical Trial Update: Macugen for Histoplasmosis [NA]
A clinical trial evaluating Macugen (pegaptanib) for ocular histoplasmosis with choroidal neovascularization has been terminated; no results…